rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Peña Chilet, Maria ^a   Ibarrola Villava, Maider ^a   Martin González, Manuel ^b   Feito, Marta ^c   Gomez Fernandez, Cristina ^c   Planelles, Dolores ^d   Carretero, Gregorio ^e   Lluch, Ana ^a   Nagore, Eduardo ^f   Ribas, Gloria ^a  

^a Instituto Universitario IVI INCLIVA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Laboratory of Histocompatibility Molecular Biology   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D BINDING PROTEIN GENE; VITAMIN D RECEPTOR GENE;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MELANOMA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SKIN NEOPLASMS; SPAIN; VITAMIN D-BINDING PROTEIN;

EID: 84875438829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059607     Document Type: Article

References (36)

1. Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ (2000) Early detection and treatment of skin cancer. Am Fam Physician 62: 357-368, 375-356, 381-352.
2. Holick MF, (2003) Vitamin D deficiency: what a pain it is. Mayo Clin Proc 78: 1457-1459.
3. Holick MF, (2003) Evolution and function of vitamin D. Recent Results Cancer Res. 164: 3-28.
4. Field S, Newton-Bishop JA, (2011) Melanoma and vitamin D. Mol Oncol. 5: 197-214.
5. Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, et al. (2011) Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer 128: 936-943.
6. Alimirah F, Peng X, Murillo G, Mehta RG, (2011) Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One 6: e16024.
7. Touvier M, Chan DS, Lau R, Aune D, Vieira R, et al. (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20: 1003-1016.
8. Smedby KE, Eloranta S, Duvefelt K, Melbye M, Humphreys K, et al. (2011) Vitamin D receptor genotypes, ultraviolet radiation exposure, and risk of non-Hodgkin lymphoma. Am J Epidemiol 173: 48-54.
9. Karami S, Brennan P, Navratilova M, Mates D, Zaridze D, et al. (2010) Vitamin d pathway genes, diet, and risk of renal cell carcinoma. Int J Endocrinol 2010: 879362.
10. Bektas-Kayhan K, Unur M, Yaylim-Eraltan I, Ergen HA, Toptas B, et al. (2010) Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma. In Vivo 24: 755-759.
11. Chang CK, Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, et al. (2011) Vitamin D Receptor Gene Variants and Esophageal Adenocarcinoma Risk: A Population-Based Case-Control Study. J Gastrointest Cancer.
12. Srinivasan M, Parwani AV, Hershberger PA, Lenzner DE, Weissfeld JL, (2010) Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol 123: 30-36.
13. Kidd LC, Paltoo DN, Wang S, Chen W, Akereyeni F, et al. (2005) Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. Prostate 64: 272-282.
14. Gapska P, Scott RJ, Serrano-Fernandez P, Mirecka A, Rassoud I, et al. (2009) Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol 33: 103-107.
15. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, et al. (2011) Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer.
16. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, et al. (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19: 2739-2745.
17. Pani MA, Regulla K, Segni M, Hofmann S, Hufner M, et al. (2002) A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. J Clin Endocrinol Metab 87: 2564-2567.
18. Disanto G, Ramagopalan SV, Para AE, Handunnetthi L, (2010) The emerging role of vitamin D binding protein in multiple sclerosis. J Neurol 258: 353-358.
19. Chishimba L, Thickett DR, Stockley RA, Wood AM, (2010) The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 65: 456-462.
20. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180-188.
21. Davies JR, Chang YM, Snowden H, Chan M, Leake S, et al. (2011) The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate. Cancer Causes Control 22: 1471-1482.
22. Barroso E, Fernandez LP, Milne RL, Pita G, Sendagorta E, et al. (2008) Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer 8: 385.
23. Laayouni H, Calafell F, Bertranpetit J, (2010) A genome-wide survey does not show the genetic distinctiveness of Basques. Hum Genet 127: 455-458.
24. The International HapMap Project. Nature 426: 789-796.
25. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
26. Newton Bishop JA, Bishop DT, (2005) The genetics of susceptibility to cutaneous melanoma. Drugs Today (Barc) 41: 193-203.
27. Kvaskoff M, Whiteman DC, Zhao ZZ, Montgomery GW, Martin NG,et al. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma. Twin Res Hum Genet 14: 422-432.
28. Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N, et al. (2009) Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 30: 769-776.
29. Poynter JN, Jacobs ET, Figueiredo JC, Lee WH, Conti DV, et al. (2010) Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 19: 525-536.
30. Hibler EA, Hu C, Jurutka PW, Martinez ME, Jacobs ET, (2012) Polymorphic Variation in the GC and CASR Genes and Associations with Vitamin D Metabolite Concentration and Metachronous Colorectal Neoplasia. Cancer Epidemiol Biomarkers Prev 21: 368-375.
31. Shen LH, Zhang XM, Su DJ, Yao SP, Yu BQ, et al. (2010) Association of vitamin D binding protein variants with susceptibility to chronic obstructive pulmonary disease. J Int Med Res 38: 1093-1098.
32. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. (2008) The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 17: 1339-1343.
33. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, et al. (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29: 3511-3536.
34. Mocellin S, Nitti D, (2008) Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 113: 2398-2407.
35. Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, et al. (2009) Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 27: 5439-5444.
36. Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, et al. (2009) Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 45: 3271-3281.